by Ubaka Ogbogu | Jan 4, 2011
In March 2009, in his remarks at the signing of an Executive Order to reverse the Bush-era stem cell research funding restrictions, President Obama directed John P. Holdren, Director of the Office of Science and Technology Policy, to “develop a strategy for restoring...
by Ubaka Ogbogu | Dec 16, 2010
President Obama’s Commission on the Study of Bioethical Issues today released a report of its ethical investigation and recommendations for oversight of the emerging field of synthetic biology. The report responds to a charge to the Commission issued by the President...
by Ubaka Ogbogu | Dec 16, 2010
Chris Kamel’s recent post on chemically derived transcription factors for iPS cell production is very exciting for a variety of non-scientific reasons. Most notably, the innovative procedure and future improvements are likely to ease ethical, safety and legal concerns...
by Michelle Ly | Nov 29, 2010
I was having my bathroom renovated a few months ago and got into a discussion with my contractor about work. I mentioned that I had done some work with the BC Cancer Research Centre and other biomedical research institutes. His comment was, “Cancer research? So do you...
by Chris Kamel | Nov 20, 2010
Because of some vocal opposition, stem cell research is no stranger to controversy. Usually this comes in the form of protests or government lobbying, but Nature News is reporting the story of a group that is trying to discredit the scientists themselves. The...
by David Kent | Nov 10, 2010
One of the most memorable moments of my PhD training was at a 2006 Keystone conference where Shinya Yamanaka presented a little something called Pluripotency and Nuclear Reprogramming. He carefully presented the transcription factor screen that would culminate in the...
Comments